More guidance is expected from the US FDA in the coming months to help combination product sponsors avoid mistakes in their requests for designation and reverse a low filing rate.
Nearly 87% of the designation requests received in fiscal year 2017 were not filed or withdrawn because of missing information or other problems. Office of Combination Products Director Thinh Nguyen...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?